A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

NCT00140972 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: MK0663; etoricoxib / Duration of Treatment:4 Weeks
DRUG: Comparator: diclofenac sodium tablet 75 mg / Duration of Treatment:4 Weeks

Sponsor

Organon and Co